SBIO vs VIG5YSBIOSBIOAvsBVIGVIGALPS Medical Breakthroughs ETF · $186MVanguard Dividend Appreciation ETF · $116BReturns · dividends in+32.1%3 years · per year$23,054 · $16,797+18.9%+3.6%5 years · per year$11,920 · $16,513+10.6%Cost and income0.50%Expense ratio$50 · $4 on $10k · lower wins0.04%0.00%12-mo yield$0 · $145 on $10k1.45%Risk · 1 year−29.2%End-of-day Nov 13, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
Both5Y2 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BVIGVanguard Dividend Appreciation ETFReadDesk0.04%1.45%0.0%+16.0%+16.3%+18.9%+10.6%−7.9%$115.8B2ASBIOALPS Medical Breakthroughs ETFReadDesk0.50%0.00%−0.5%+8.6%+20.4%+32.1%+3.6%−29.2%$186MEnd-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
Both5Y2 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BVIGVanguard Dividend Appreciation ETFReadDesk0.04%1.45%0.0%+16.0%+16.3%+18.9%+10.6%−7.9%$115.8B2ASBIOALPS Medical Breakthroughs ETFReadDesk0.50%0.00%−0.5%+8.6%+20.4%+32.1%+3.6%−29.2%$186MEnd-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
Overlap: SBIO, VIGToday0.0%most shared, SBIO and VIGSBIOVIGSBIO—0.0%VIG0.0%—End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus
SBIO vs VIG5YASBIOALPS Medical Breakthroughs$11,920vsVIGBVanguard Dividend Appreciation$16,513$10k$15kNov 2021Nov 2026
SCHD vs VIGYTDSchwabSCHDSA+34.9%vsBVVIGVanguard+16.0%Jan 1Nov 13+34.9%+16.0%+34.9%Year to date+16.0%2.9%Yield1.4%$124BAssets$116B2–0SCHD winsEnd-of-day Nov 13, 2026
DGRO vs VIGYTDiSharesDGROiSA+19.9%vsBVVIGVanguard+16.0%Jan 1Nov 13+19.9%+16.0%+19.9%Year to date+16.0%1.8%Yield1.4%$46.0BAssets$116B2–0DGRO winsEnd-of-day Nov 13, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+6.7%vsBJMJEPIJ.P. Morgan+8.2%Jan 1Nov 13+6.7%+8.2%+6.7%Year to date+8.2%12.4%Yield7.9%$42.1BAssets$47.0B1–1levelEnd-of-day Nov 13, 2026
Overlap: SBIO, VIGToday0.0%most shared, SBIO and VIGSBIOVIGSBIO—0.0%VIG0.0%—End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$141most kept, VIGVIG$145 − $4 = $141SBIO$0 − $50 = −$50KeptFeeEnd-of-day Nov 13, 2026 · yield in dollars minus the fee